TipRanks on MSN
Enad Global 7 AB Announces Q3 2025 Results Presentation
Enad Global 7 AB ( ($SE:EG7) ) just unveiled an update. Enad Global 7 AB has announced a live presentation for its third-quarter results of 2025, ...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that new data on ...
Localized supply chains are crucial for mitigating geopolitical risks and ensuring operational continuity in the biopharmaceutical sector. Regulatory harmonization enhances access to medicines, ...
In this part 2 of a 2-part interview regarding the presentation “Beyond Traditional Markets: The Strategic Importance of ...
The federal government is seeking the power to cancel applications for groups of visa holders at least in part due to concerns of fraud from India and Bangladesh, according to internal documents ...
Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the ...
Visual content depicting climate activists emphasizes emotion and disruption, contrasting with the rational, data-driven ...
VYVGART demonstrated clinically meaningful benefit across all AChR-Ab seronegative gMG subtypes in ADAPT SERON, supporting broad role of pathogenic IgGs in disease activityFinal ADAPT SC+ results show ...
Operator: Good morning, and good evening. Thank you all for joining the conference call for the SK Telecom earnings results.
RedChip Companies will host an investor webinar with Connect Biopharma Holdings Limited (Nasdaq:CNTB) (Connect Biopharma, ...
Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan,  /PRNewswire/ -- Johnson & ...
Basel, October 29, 2025 – Novartis today presented new ianalumab data in Sjögren’s disease, the second most prevalent rheumatic autoimmune disease 2, at a late-breaker presentation during the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results